- STAT+: Fatal gene-editing trial in China raises ethics and oversight questionsSanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The ReadoutSTAT · 1h ago↗ source
- STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and moreIn a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugsSTAT · 1h ago↗ source
- Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…